Kindly MD, Inc. (KDLY) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 4.69M
• Price to Earnings (P/E): ―
• Beta (1Y): 4.57
• Revenue Growth: -28.13%
• EPS Growth: -153.45%
• Country: US
• Employees: 23
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Equipment & Services
• EPS (TTM): -0.73
• Shares Outstanding: 6,022,148
• 10 Day Avg. Volume: 13,687,850
• 30 Day Avg. Volume: 4,685,476
• PEG Ratio: 0.25
• Price to Book (P/B): 9.16
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -6.77
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: 1.82
• Enterprise Value/Gross Profit: 31.47
• Enterprise Value/Ebitda: -2.60
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 54 Neutral
• Price Target: $25.00 ▲( 0.24% Upside)

Kindly MD, Inc.'s overall stock score is primarily driven by the financial struggles highlighted in the financial performance analysis. Despite the stock's bullish momentum, high volatility and potential overbought conditions warrant caution. Valuation metrics are unfavorable due to negative earnings and lack of dividends. However, strategic corporate events involving Bitcoin may offer long-term growth prospects, partially offsetting financial weaknesses.

Kindly MD, Inc. Business Overview & Revenue Model

Company Description

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

How the Company Makes Money

Kindly MD, Inc. generates revenue through a combination of service fees for telemedicine consultations, subscription-based models for chronic disease management programs, and partnerships with healthcare providers and organizations. The company may also receive compensation through insurance reimbursements and direct payments from patients. Significant partnerships with technology companies and healthcare institutions contribute to its earnings by expanding its reach and enhancing the service offerings. Kindly MD's focus on personalized healthcare and technology integration allows it to differentiate its services, thereby attracting a broad client base and ensuring multiple revenue streams.

Kindly MD, Inc. Financial Statement Overview

Summary

Kindly MD, Inc. is facing significant financial challenges, with declining revenues and profitability issues. Although the balance sheet shows some stability with a moderate debt level, negative equity in 2023 and reliance on financing raise concerns. Cash flow struggles highlight the need for better operational efficiency and cost management to improve financial health. The company must focus on strategic initiatives to achieve sustainable revenue growth and profitability.

Income Statement

Kindly MD, Inc. has faced significant challenges in revenue and profit growth. The Gross Profit Margin remains high at 96.95% for 2024, but the Net Profit Margin is negative at -133.00%, indicating substantial losses. The company has faced revenue decline from the previous year, further exacerbating its profitability issues. The negative EBIT and EBITDA margins highlight operational inefficiencies and the need for cost management.

Balance Sheet

The company's Debt-to-Equity Ratio is 0.31, indicating a moderate level of leverage. However, the negative equity in 2023 raises concerns about financial stability. The Return on Equity is not meaningful due to negative equity in 2023, but the Equity Ratio improved to 69.82% in 2024, reflecting better asset financing through equity.

Cash Flow

Cash flow analysis shows a negative Free Cash Flow of -$3.09 million in 2024, indicating cash management struggles. The Operating Cash Flow to Net Income Ratio is negative, reflecting inefficiencies in converting income into cash. The company heavily relies on financing activities to support its cash needs, which may not be sustainable in the long term.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement		Total Revenue
2.72M	3.77M	3.79M	2.50M
	Gross Profit
2.64M	-158.53K	-595.29K	914.92K
	EBIT
-3.35M	-1.62M	-2.69M	61.34K
	EBITDA
-3.00M	-1.36M	-2.42M	66.19K
	Net Income Common Stockholders
-3.62M	-1.62M	-2.54M	149.34K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.27M	525.50K	186.92K	94.69K
	Total Assets
3.68M	1.10M	947.00K	447.64K
	Total Debt
783.68K	636.38K	391.13K	109.81K
	Net Debt
-1.49M	110.88K	204.21K	15.12K
	Total Liabilities
1.11M	1.21M	565.98K	174.56K
	Stockholders Equity
2.57M	-108.41K	381.01K	273.09K
Cash Flow		Free Cash Flow
-3.09M	-463.91K	-457.77K	57.84K
	Operating Cash Flow
-3.07M	-449.49K	-140.38K	121.44K
	Investing Cash Flow
-401.63K	-14.42K	-317.39K	-63.60K
	Financing Cash Flow
5.22M	802.49K	550.00K	-45.34K

Kindly MD, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 24.94
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KDLY, the sentiment is Positive. The current price of 24.94 is above the 20-day moving average (MA) of 9.21, above the 50-day MA of 4.69, and above the 200-day MA of 2.21, indicating a bullish trend. The MACD of 5.08 indicates Negative momentum. The RSI at 75.58 is Negative, neither overbought nor oversold. The STOCH value of 62.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KDLY.

Kindly MD, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BTSG	70 Outperform	$4.15B	84.36	2.30%	―	23.40%	―
AUNA	64 Neutral	$504.77M	11.91	9.93%	―	6.97%	―
AS	58 Neutral	$20.76B	100.83	4.38%	―	21.21%	―
Sector *	57 Neutral	$4.84B	20.17	-16.90%	5.21%	13.60%	-28.06%
KDLY	54 Neutral		―	-763.28%	―	-28.13%	-153.45%
CORZ	40 Underperform	$3.23B	―	160.33%	―	-26.76%	-1883.89%
BKHA			36.30	7.41%	―	―	―

Kindly MD, Inc. Corporate Events

KindlyMD Partners with Anchorage for Bitcoin Strategy

On May 21, 2025, KindlyMD Inc. and Nakamoto Holdings announced a strategic partnership with Anchorage Digital, a federally chartered digital asset bank, to provide exclusive custody and trading services for KindlyMD’s Bitcoin treasury operations. This partnership, following a merger agreement between KindlyMD and Nakamoto, aims to advance corporate Bitcoin adoption by establishing a Bitcoin treasury strategy. The collaboration is backed by $710 million in financing, marking the largest PIPE for a public crypto-related transaction, and is expected to position Bitcoin at the center of corporate strategy, enhancing value for shareholders and stakeholders.

KindlyMD Announces Merger with Nakamoto Holdings

On May 18, 2025, KindlyMD, Inc. announced that its majority shareholders approved a merger agreement with Nakamoto Holdings Inc., a Bitcoin-native holding company. The merger, expected to close in the third quarter of 2025, aims to integrate Bitcoin into KindlyMD’s operations, potentially enhancing its market position and providing long-term value for investors. This strategic move reflects a shared vision of incorporating Bitcoin as a core asset, with the merger set to bring significant changes to KindlyMD’s capital structure and governance.

Kindly MD, Inc. Updates Executive Employment Agreements

On May 12, 2025, Kindly MD, Inc. made significant changes to the executive employment agreements of its top executives, including CEO Tim Pickett, CFO Jared Barrera, and COO Adam Cox. These changes involved modifications to stock options, vesting schedules, and a waiver of rights to future equity in the company and its affiliates. Additionally, independent directors received adjusted stock options and restricted stock, with all options priced based on the prior day’s closing stock price. Following these changes, the company has issued 730,923 shares of common stock through warrant exercises, generating $4,219,584.33 by May 15, 2025.

KindlyMD Announces Merger with Nakamoto Holdings

On May 12, 2025, KindlyMD, Inc. announced a merger agreement with Nakamoto Holdings Inc., a Bitcoin-native holding company, to establish a Bitcoin treasury strategy. This merger aims to position the combined entity as a leading public market Bitcoin treasury, leveraging Nakamoto’s expertise in Bitcoin strategy and KindlyMD’s healthcare operations. The merger, supported by a $510 million PIPE financing and $200 million in convertible notes, reflects a strategic move to integrate Bitcoin into global capital markets. The transaction, which requires shareholder approval, is expected to bring long-term value to shareholders by combining healthcare services with Bitcoin treasury management.